首頁 > 市場調查報告書 > 食物/飲料

食品添加劑

市場調查報告書

商品編碼

1423448

全球低聚果糖市場 - 2023-2030

Global Fructo-Oligosaccharides Market - 2023-2030

出版日期: 2024年02月09日 | 出版商:

DataM Intelligence | 英文 171 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年全球低聚果糖市場規模達32.1億美元，預計2030年將達到59.9億美元，2023-2030年預測期間CAGR為8.1%。

低聚果糖甜度低，不致齲，可作為可溶性膳食纖維。該產品的低熱量特性促使其作為糖替代品應用於各種食品和非食品領域，例如嬰兒配方奶粉、食品和飲料、膳食補充劑、動物飼料和藥品。本產品有固體、液體兩種形式，或可方便有效地應用於所需的產品中。

產品的各種功能優勢推動了產品的更多生產需求。製造商在產品製造中採用永續實踐正在擴大全球市場的正面影響力。製造商正在投資綠色化學，作為低能源強度和零排放永續發展承諾的一部分。例如，塔塔化學品有限公司開發了一種發酵平台，這是一種從糖生產低聚果糖的技術。

北美主導了市場成長。根據美國疾病管制與預防中心 (CDC) 統計，約有 3,730 萬美國人患有糖尿病，約占美國人口的 11.3%。生活方式障礙的日益流行正在提高消費者的健康意識，推動北美地區對糖替代品的需求，並對市場成長產生積極影響。

動力學

低聚果糖的功能優勢

低聚果糖是非致齲性的，它們被用作可溶性膳食纖維。它們是可溶性膳食纖維的良好來源，可促進減少或消除便秘。它們還可以透過抑制與食物中毒相關的有毒細菌來支持消化道中健康細菌的生長。

低聚果糖不可消化，可以完整地通過小腸到達結腸，在那裡它們支持健康細菌的生長，從而有助於維持適當的消化健康。低聚果糖用作益生元補充劑的成分。低聚果糖具有有益的生理作用，例如改善礦物質吸收。

大量使用低聚果糖作為替代糖

根據世界衛生組織2022年統計，全球有超過10億人患有肥胖症，其中6.5億人是成年人，3.4億人是青少年。兒童肥胖的嚴重程度也在增加，根據世界衛生組織的統計，2022 年兒童肥胖人數高達 3,900 萬人。

根據 IDF 2021 年糖尿病圖譜，全球有 5.37 億成年人患有糖尿病。該組織報告稱，肥胖症和糖尿病的盛行率正在迅速增加，預計到2030 年將達到6.43 億。由於高熱量消費，全球肥胖和糖尿病盛行率不斷增加，因此對低熱量替代甜味劑的需求更大。

低聚果糖主要用作低熱量的替代甜味劑。它們味道細膩香甜，熱量低，提供的熱量不到蔗糖的一半。這些低聚果糖不易消化，因此不會影響血糖值。它們被用於各種食品應用，作為推動市場成長的替代糖。

低聚果糖的高成本和潛在副作用

低聚果糖的高成本可能是全球市場成長的主要限制因素之一。較低的產量、較高的生產成本、複雜的純化和品質控制是導致低聚果糖成本較高的一些因素。對價格敏感的最終用戶可能會採用其他更便宜的糖替代品，而放棄該產品。

過度使用低聚果糖可能會導致一些潛在的副作用，例如腹瀉、腹脹和胃痙攣。副作用也可能是由於果糖不耐症造成的。大量使用會導致胃部不適並傷害腸躁症患者。

Fructo-oligosaccharides have a low sweetness intensity, non-cariogenic and used as soluble dietary fibres. The low-calorie nature of the product drives its use as a sugar alternative for applications in various categories of food and non-food segments such as infant formulation, food & beverages, dietary supplements, animal feed and pharmaceuticals. The product is available in solid in liquid form or its convenient and effective application in required products.

Various functional benefits of the product drive the product demand for more production. The adoption of sustainable practices by manufacturers for product manufacturing is expanding the positive reach of the market at the global level. Manufacturers are investing in Green Chemistry as part of the sustainability commitment to low energy intensity and zero effluents. For instance, TATA Chemicals Limited developed a Fermentation Platform, a technology to produce fructo-oligosaccharides from sugar.

North America dominated the market growth. According to the CDC, about 37.3 million Americans are suffering from diabetes, covering about 11.3 % of the United States population. The increasing prevalence of lifestyle disorders is raising the health consciousness among consumers driving the need for sugar alternatives in North America, and positively impacting market growth.

Dynamics

Functional Benefits of Fructo-Oligosaccharides

Fructo-oligosaccharides are non-cariogenic, they are set to be used as soluble dietary fibers. They are good sources of soluble, dietary fiber and promote the reduction or elimination of constipation. They also support the growth of healthy bacteria in the digestive tract by suppressing toxic bacteria associated with food poisoning.

Fructo-oligosaccharides are non-digestible and travel intact through the small intestine to the colon, where they support the growth of healthy bacteria which help in maintaining proper digestive health. Fructo-oligosaccharides are used as an ingredient in prebiotic supplements. Fructo-oligosaccharides have beneficial physiological effects such as improved mineral absorption.

High Use of Fructo-Oligosaccharides as an Alternative Sugar

According to the World Health Organization 2022 statistics, more than 1 billion people globally are suffering from obesity, where 650 million people are adults and 340 million are adolescents. The severity of obesity is increasing in children too, accounting for up to 39 million according to 2022, WHO statistics.

According to IDF Diabetes Atlas 2021, 537 million adults are living with diabetes in the world. The organization reports that the prevalence is increasing rapidly and is estimated to reach 643 million by 2030. With the increasing prevalence of obesity and diabetes globally due to high-calorie consumption, there is a greater need for low-calorie, alternative sweeteners.

Fructo-oligosaccharides are used primarily as a low-calorie, alternative sweetener. They are delicate sweet flavor has low calories, and provide less than half the caloric value of sucrose. These fructooligosaccharides are non-digestible, so they don't affect blood sugar levels. These are used in various food applications as an alternative sugar driving market growth.

High Cost and Potential Side Effects of the Fructo-Oligosaccharides

The high cost of fructo-oligosaccharides can be one of the major restraining factors for global market growth. The lower yield, high production costs, complex purification and quality control are some of the factors that contribute to the high cost of the fructo-oligosaccharides. The price-sensitive end-users may take up other alternative less expensive sugar alternatives, leaving the product behind.

The overuse of fructo-oligosaccharides may cause some of the potential side effects such as diarrhea, bloating and stomach cramps. The side effects can also be due to the which can be fructose intolerance. The high use can lead to gastric distress and hurt people with irritable bowel syndrome.

Segment Analysis

The global fructo-oligosaccharides market is segmented based on source, form, application and region.

High Demand for Low-Calorie Food and Beverage Products

The global fructo-oligosaccharides market is segmented based on application into infant formulation, food & and beverages, dietary supplements, animal feed, and pharmaceuticals. Food and beverage accounted for the largest share of the global market due to increased demand for low-calorie food products. With the increasing health concerns related to high-sugar products, there is a surge in demand for sugar alternatives for their use in the production of low-calorie food and beverages.

The fructo-oligosaccharides have multiple applications in the food and beverage sectors such as confectionery, bakery, beverages, desserts and others. The new product launch for their application in the food and beverages sectors drives the segment growth. For instance, in May 2023, BENEO, the company that offers naturally sourced, functional ingredients announced the launch of Beneo-scL85 ingredients for sugar reduction. These ingredients are actively used in various food applications such as bakery, dairy, and cereals.

Geographical Penetration

Increasing Demand for Low-Calorie Products In North America

North America dominated the global fructo-oligosaccharides market. With the increasing health consciousness among consumers, there is a greater need for healthy alternatives for various food products in this region. The region has an increased prevalence of obesity and diabetes driving the need for alternative sugar products for its use in multiple food product manufacturing.

According to the Centers for Disease Control and Prevention 2023, obesity affects over 41.9 % of adults and 19.7 % of children in the United States. The American Heart Association recommends the strict restriction of less than 100 sugar calories per day for most adult women and less than 150 sugar calories per day for most men, motivating consumers to take low-calorie products, and increasing the demand for sugar alternatives.

Competitive Landscape

The major global players in the market include BENEO, Cargill, Incorporated, Ingredion, Tereos, Biosynth, Tate & Lyle, Galam Group, TATA Chemicals Limited, AVANSCHEM and Merck KGaA.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic had a positive impact on the global fructo-oligosaccharides market. Even though the pandemic created greater challenges for the market manufacturers in the production and distribution of the product to the end-user due to interrupted supply chain activities, the market then increased its sales through the use of e-commerce platforms and high demand from the end-use industries.

According to NIH 2020, obesity and diabetes are two major risk factors for COVID-19 hospitalization. The organization stated that people with diabetes mellitus and severe obesity are more likely to get infected and are at a higher risk of mortality from COVID-19. Among elderly patients who are at higher risk of death from COVID-19, 26.8% have diabetes mellitus. To maintain their calorie intake, increased consumer preference towards low-calorie products.

By Source

Sucrose
Inulin

By Form

Liquid
Powder

By Application

Infant Formulation
Food & Beverages
Dietary Supplements
Animal Feed
Pharmaceuticals

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In May 2023, BENEO, the company that offers naturally sourced, functional ingredients announced the launch of Beneo-scL85 ingredients for sugar reduction. These ingredients are actively used in various food applications such as bakery, dairy, and cereals.
In March 2022, Tate & Lyle PLC, a leading global provider of food and beverage ingredients and solutions, signed the agreement to acquire Quantum Hi-Tech Biological Co. Ltd, the company that is involved in the production and marketing of fructo-oligosaccharides.
In June 2020, Galam, the global nutrition ingredients manufacturer of specialty ingredients for the food and animal nutrition industries, incorporated two new fructooligosaccharides production plants with an investment of about USD 20 million.

Why Purchase the Report?

To visualize the global fructo-oligosaccharides market segmentation based on source, form, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of fructo-oligosaccharides market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global fructo-oligosaccharides market report would provide approximately 62 tables, 52 figures and 171 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Source
3.2. Snippet by Form
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Functional Benefits of Fructo-Oligosaccharides
  - 4.1.1.2. High Use as an Alternative Sugar
- 4.1.2. Restraints
  - 4.1.2.1. High Cost and Potential Side Effects of the Fructo-Oligosaccharides
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Source

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 7.1.2. Market Attractiveness Index, By Source
7.2. Sucrose
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Inulin

8. By Form

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2. Market Attractiveness Index, By Form
8.2. Liquid
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Powder

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Infant Formulation
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Food & Beverages
9.4. Dietary Supplements
9.5. Animal Feed
9.6. Pharmaceuticals

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. BENEO
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Cargill, Incorporated
12.3. Ingredion
12.4. Tereos
12.5. Biosynth
12.6. Tate & Lyle
12.7. Galam Group
12.8. TATA Chemicals Limited
12.9. AVANSCHEM
12.10. Merck KGaA

LIST NOT EXHAUSTIVE